Search Tag: Masimo

ICU Management

Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists

2016 29 Sep

Joint Initiative, “Safe Anaesthesia – ASAP,” Is to Improve Anesthesia Care in Low Resource CountriesMasimo (NASDAQ: MASI) has announced at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesthesiologists (WFSA). The four-year partnership, “Safe Anaesthesia... Read more

ICU Management

Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI®

2016 15 Sep

Masimo (NASDAQ: MASI) has announced the findings of a study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong. In the study, researchers at Cairo University in Egypt investigated the clinical utility of a Masimo SET® noninvasive, continuous measurement, PVI®.In the prospective study of 60 adult patients undergoing major... Read more

ICU Management

Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry

2016 04 Aug

Masimo (NASDAQ: MASI) has announced the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, helps clinicians monitor cerebral oxygenation.O3 regional oximetry uses near-infrared spectroscopy (NIRS) to continuously monitor absolute and trended... Read more

ICU Management

DHZB Adopts Masimo’s SedLine® Brain Function Monitoring & O3™ Regional Oximetry

2016 08 Jul

Masimo (NASDAQ: MASI) has announced  that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry technologies to monitor patients in the operating room and intensive care unit.“Our non-profit hospital performs over 32,000 treatments each year.... Read more

ICU Management

Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology

2016 28 Jun

Radius-7 is the First Wearable, Tetherless, Noninvasive rainbow® Monitor Masimo (NASDAQ: MASI) has announced FDA 510(k) clearance for Radius-7® – the first and only wearable, tetherless, noninvasive rainbow® monitor. Radius-7, which connects to the Root® patient monitoring and connectivity platform, is now available in the U.S. with breakthrough Masimo... Read more

ICU Management

New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology

2016 23 Jun

Masimo (NASDAQ: MASI) and SunTech Medical, a Halma (LSE:HLMA) company, jointly has announced the integration of Masimo SET® pulse oximetry technology into SunTech’s CT40, a next generation spot-check vital signs device.Masimo Signal Extraction Technology (SET®) Measure-through Motion and Low Perfusion™ pulse oximetry measures oxygen saturation (SpO2),... Read more

ICU Management

Masimo Announces 510(k) Clearance for O3™ Regional Oximetry

2016 13 Jun

Masimo (NASDAQ: MASI) has announced FDA 510(k) clearance for O3™ regional oximetry. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain due to various factors, such as the type of clinical... Read more

ICU Management

Masimo Announces Full Market Release of Next Generation SpHb® Spot Check Pronto®

2016 08 Jun

Masimo (NASDAQ: MASI) has announced the full market release outside the U.S. of the Pronto® Pulse CO-Oximeter® with Next Generation SpHb® Spot Check technology. Next Generation Pronto features rainbow SET™ technology, for noninvasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI).In addition... Read more

ICU Management

India’s Motherhood Hospitals, Standardizes on Masimo SET® Technology

2016 02 Jun

Masimo (NASDAQ: MASI) has announced that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET® (Signal Extraction Technology) pulse oximetry at all locations. Motherhood Hospitals will also be screening for Critical Congenital Heart Disease (CCHD) using Masimo’s technology.“We... Read more

ICU Management

Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress

2016 27 May

SedLine, Which Helps Clinicians Improve Anesthetic Management, Receives CE MarkMasimo (NASDAQ: MASI) announced today the CE mark and scheduled full market release of Next Generation SedLine® Brain Function Monitoring technology at the European Society of Anaesthesiology's (ESA) 2016 Euroanaesthesia Congress in London, England.Next Generation SedLine... Read more

Endorsed Companies